Fullerton deal is no side gig for Japan Inc
Mitsubishi’s latest investment in Singapore’s Fullerton Health underscores how Japan Inc has been swooping in on healthcare assets across South-east Asia and reshaping the sector – block by block
DeeperDive is a beta AI feature. Refer to full articles for the facts.
“WHERE there’s a will, there’s a way” could well sum up Japan Inc’s quiet but profound pivot into South-east Asia’s lucrative private healthcare space, where demand outruns capacity.
When Sumitomo – the Japanese conglomerate – swooped in to acquire Malaysia’s CareClinics Healthcare Services in 2020, the climate was unforgiving. The deal was sealed at the height of the pandemic with travel and movement curbs turning negotiations and integration issues into a logistical nightmare.
But it paid off. Four years later, Sumitomo has grown that small foothold into the country’s largest private clinic network with over 100 clinics; it plans to triple this by 2026.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.
TRENDING NOW
‘Boring’ is the new black: The stars are aligning for a Singapore stock market revival
Near sell-out launches in March boost developer sales to 1,300 units after four slow months
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Genting Singapore’s Lim Kok Thay receives S$7.5 million pay package for FY2025